A collaborative effort to improve treatments for infectious diseases.
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
This study is working with a team of experts to find new vaccines and treatments for infections like colds, stomach bugs, malaria, and sexually transmitted infections, so that patients from different backgrounds can benefit from better health options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10992618 on NIH RePORTER |
What this research studies
This research involves a national partnership of experts in infectious diseases and clinical research, focusing on developing and implementing clinical trials for various infections, including respiratory and enteric infections, malaria, and sexually transmitted infections. The consortium aims to facilitate innovative approaches to address clinical research priorities set by the NIH/NIAID. Patients may benefit from new vaccines, therapeutics, and diagnostics that emerge from these trials, which will involve diverse populations and cutting-edge methodologies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals affected by respiratory infections, enteric infections, malaria, or STIs, as well as those at risk for emerging infectious diseases.
Not a fit: Patients with non-infectious diseases or those not affected by the targeted infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases, improving patient outcomes.
How similar studies have performed: Previous research has shown success in similar collaborative approaches to infectious disease treatment, indicating a strong potential for impactful outcomes.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Stephens, David S — Emory University
- Study coordinator: Stephens, David S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.